Sumitomo Dainippon Pharma Co Ltd - Ebit

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Ebit" stands at 15.99 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 03/31/2023.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 20.98 Billion JPY for the item "Ebit" represents an increase of 10,437.44 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 20.98 Billion JPY for the item "Ebit" represents an increase of 9.14 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 15.99 Billion JPY for the item "Ebit" represents an increase of 12.35 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 268.61 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 268.61 Billion Japanese Yens.
The 3 year change is -108.60 Billion Japanese Yens.
The 5 year change is -51.90 Billion Japanese Yens.
The 10 year change is -15.10 Billion Japanese Yens.

The Serie's long term average value is 28.02 Billion Japanese Yens. It's latest available value, on 06/30/2025, is -12.03 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2024, to it's latest available value, on 06/30/2025, is +318.09 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -108.60 Billion.